Core Insights - Greenhaven Road Capital reported a third-quarter 2025 return of approximately -9%, with year-to-date returns also at -9% due to factors such as lack of investment in AI and insufficient holdings in small, high-growth companies [1] Company Overview - Cellebrite DI Ltd. (NASDAQ:CLBT) is a software company focused on solutions for legally sanctioned investigations, headquartered in Petah Tikva, Israel [2] - The stock of Cellebrite DI Ltd. experienced a one-month return of -21.27% and a 52-week decline of 16.17%, closing at $15.40 per share with a market capitalization of $3.765 billion as of November 7, 2025 [2] Financial Performance - Cellebrite DI Ltd. reported Q2 2025 revenue of $113.3 million, an 18% increase from Q2 2024, driven by a 21% growth in subscription revenue [4] Market Position and Valuation - The Enterprise Value to Next 12 Months Revenue for medium growth companies, which includes Cellebrite, declined from 10.6X at the start of the year to 7.8X by the end of Q3, indicating a 26% decrease in valuation metrics for medium growth software companies [3] - Cellebrite DI Ltd. was held by 38 hedge fund portfolios at the end of Q2 2025, an increase from 30 in the previous quarter, but it is not among the 30 most popular stocks among hedge funds [4]